Press & News

Press & News2020-02-25T19:19:07+00:00

Latest Articles

Browse a selection of ImaginAb press and news below.

2709, 2019

Dr. James Allison’s gripping documentary, Breakthrough

ImaginAb celebrates the first screenings of Science Advisory Board member Dr. James Allison’s gripping documentary, Breakthrough, chronicling his discovery of the ground-breaking medicine that would become pivotal in the development of immunotherapy treatments for cancer.

2509, 2019

ImaginAb Enrolls First Patient at the University of Alabama at Birmingham in On-going “Base Line/On Therapy” (BOT) Phase II Clinical Trial

ImaginAb Inc., a clinical-stage immuno-oncology imaging company, today announces it has enrolled its first patient for the Phase II clinical trial of its lead product CD8 tracer, 89Zr-Df-IAB22M2C, at the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham (UAB). This study is a collaboration between UAB’s Division of Hematology and Oncology and Division of Molecular Imaging and Therapeutics, reflecting UAB’s commitment to world-class research and clinical care.

409, 2019

ImaginAb to Present at Upcoming Investor and Scientific Conferences in September & October 2019

ImaginAb Inc., a clinical-stage immuno-oncology imaging company, today announces that it is scheduled to attend and/or present at the following investor and scientific conferences in September and October 2019: Word Molecular Imaging Congress, ESMO Congress, Cavendish Global Conference: The 2019 Phoenix BioHealth Impact Forum, 2nd Annual Advances in Immuno-Oncology USA Congress, and Optimum 11th Annual Healthcare Investor Conference.

907, 2019

ImaginAb Announces Collaboration on CD8 Imaging Agent with Roche

ImaginAb Inc., a clinical stage immuno-oncology imaging company, announced today that it has entered into a non-exclusive license and collaboration agreement with Roche, a leading pharmaceutical company focused on cancer treatment and diagnostics.

2006, 2019

ImaginAb to Present at SNMMI 2019 Annual Meeting

ImaginAb, Inc., a clinical stage immuno-oncology imaging company, today announces that it will attend and present at the upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting being held June 22-25, 2019, at the Anaheim Convention Center, Anaheim, California.

Load More Posts